Skip to main content

Investor RelationsWealth Management:  CA  |  UK  |  AU


John Fang

Managing Director

John Fang joined Canaccord Genuity through the acquisition of Petsky Prunier and serves as a managing director in the firm’s New York City office. John’s investment banking coverage focuses on sectors where technology, healthcare, and consumer/retail intersect, including e-commerce, healthcare technology, and fintech.

Previously, John was co-founder and managing partner of Parcrest Advisors, where he built a thriving firm in less than two years and successfully sourced and closed transactions in the healthcare, technology, and e-commerce sectors, including a number of cross-border engagements. He has advised on a wide range of transaction types, including mergers, acquisitions, divestitures, carve-outs, private equity-backed secondary sales, private debt and equity financings, distressed debt sales, loan portfolio sales, growth capital investments, recapitalizations, in and out-of-court restructurings (including DIP financings, §363 asset sales, and Chapter 11 reorganizations), and joint ventures.

John's clients have included Fortune 50 companies, founder-backed ventures, global publicly traded businesses, and private equity portfolio companies. With his experience as a senior banker at Sonenshine Partners, a well-known M&A boutique, and his restructuring work in the Debt Origination & Restructuring group of Raymond James Financial, John brings a wide range of creative and unique advisory skills to assist his clients and their companies. John began his career as an investment banker at Merrill Lynch and holds an A.B. magna cum laude with highest honors from Harvard College, where he was a Harvard College Scholar. He also holds an MBA in Finance from the Wharton School at the University of Pennsylvania, where he was elected to the Director’s List multiple times.


+1 212 842 6019

Location: New York, US

Selected transactions completed include:


Additional selected transactions completed include:

(Please note all transactions occurred prior to joining Canaccord Genuity)

  • Sale to JackRabbit
  • Sale of Allied Vision Group to Hammond, Kennedy, Whitney
  • Sale of to Walgreens for $433MM
  • Sale of to Winona Capital
  • Sale of Simbionix to 3D Systems for $120MM
  • Acquisition of Investor Analytics by StatPro plc
  • Acquisition of UBS Delta by StatPro plc
  • Sale of Realtime Technologies to Dassault Systèmes for €180MM
  • Sale of to for $39MM
  • Sale of to The Hut Group
  • Sale of 1-800 CONTACTS to WellPoint (Anthem Health) for $900MM
  • Sale of to 1-800 FLOWERS
  • Sale of to Essilor
  • Acquisition financing of $30MM from Bank of Montreal to IRIS
  • Sale of IRIS to New Look Eyewear for $90M
  • Sale of Optical Distributor Group to ABB Concise and New Mountain Capital for $350MM
  • Sale of HearUSA to Siemens for $135MM
  • Sale of incadea to Dealertrack for $190MM
  • Sale of to Rakuten for $47MM
  • Private Investment in Public Equities (PIPE) of $250MM by Lavazza into Green Mountain Coffee Roasters
  • Sale of Medical Simulation Corporation to Mentice
  • Restructuring of Palm Harbor Homes in to Cavco Industries
  • Sale of The Philadelphia Inquirer to private investor group
  • Restructuring of Provident Royalties for $500MM

How can we help?

If you would like to find out more about Canaccord Genuity or any of our services, please get in touch.

Back to top